# SpyGlass Pharma (SGP) — Analyst Forecast

SGP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sgp/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 5, 2026 | HC Wainwright & Co. | Maintained | Buy | $37.00 |
| Aug 14, 2026 | Raymond James | Initiated Coverage | Outperform | $39.00 |
| Mar 10, 2026 | HC Wainwright & Co. | Initiated Coverage | Buy | $37.00 |
| Mar 3, 2026 | Leerink Partners | Initiated Coverage | Outperform | $42.00 |
| Mar 3, 2026 | Citigroup | Initiated Coverage | Buy | $42.00 |
| Mar 3, 2026 | Jefferies | Initiated Coverage | Buy | $62.00 |
| Mar 3, 2026 | Stifel | Initiated Coverage | Buy | $42.00 |

## Frequently Asked Questions

### What is the latest analyst rating on SGP?

On Oct 5, 2026, HC Wainwright & Co. maintained SpyGlass Pharma at Buy with a price target of $37.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).